Granulocyte macrophage-colony stimulating factor for treatment of chemotherapy extravasation

European Journal of Gynaecological Oncology

Volumn 19, Issue 5, 1998, Pages 479-481

  Shamseddine, A I ^a   Khalil, A M ^a   Kibb, A G ^a   Abu Nasr, T A ^a   Seoud, M A F ^a   El Saghir, N S ^a  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

Author keywords

Extravasation ulcer; GM CSF; Wound healing

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CASE REPORT; COMBINATION CHEMOTHERAPY; EXTRAVASATION; FEMALE; HUMAN; METASTASIS; SUBCUTANEOUS DRUG ADMINISTRATION;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; DOXORUBICIN; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; FEMALE; FOLLOW-UP STUDIES; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HAND; HUMANS; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; SKIN ULCER; WOUND HEALING;

EID: 0031756665     PISSN: 03922936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Rudolph R., Stein S. R., Patillo A. R.: "Skin ulcers due to adriamycin". Cancer, 1976, 38, 1087.
2. Rudolph R., Larson L. D.: "Etiology and treatment of chemotherapeutic agent extravasation injuries. A review". J. Clin. Oncol., 1987, 5, 1116.
3. Larson L. D.: "Treatment of tissue extravasation by antitumour agents". Cancer, 1982, 49, 1796.
4. Olver N. I , Aisner J., Hament A. et al : "A prospective study of topical dimethyl sulfoxide for treating anthracycline extravasation". J. Clin. Oncol., 1988, 6, 1732.
5. Weisbart R. H.: "Colony-stimulating factors and host defense". Ann. Intern. Med., 1989, 110 (4), 297.
6. Boente P., Sampato C., Bamdao A. M. et al.: "Local perilesional therapy with rh GM-CSF for Kaposi sarcoma". Lancet, 1993, 341, 1154 (letter).
7. William C. K.: "Growth factor and wound healing". Seminars in Vascular Surgery, 1992, 5, 249.
8. Reilly J. J., Neifel P. J., Rosenberg A. S.: "Clinical course and management of accidental adriamycin extravasation". Cancer. 1977, 40, 2053
9. Garniek M., Israel M..,Khetarpal V., Luce K.: "Persistence of anthracycline levels following dermal and subcutaneous adriamycin extravasation". Proc. Am. Assoc. Cancer Res., 1981, 22, 173.
10. [101 Luedke D. W., Kennedy P. S., Rietschel R. L.: "Histopathogenesis of skin and subcutaneous injury caused by adriamycin". Plast. Reconstr. Surg., 1979, 63, 463.
11. Arnaout M. A., Wang E. A., Clark S. C., Sieff C. A : "Human recombinant granulocyte-macrophage colony-stimulating factor increases cell-to-cell adhesion and surface expression of adhesion promoting surface glycoprotein on mature granulocytes" J. Clin. Invest., 1986, 64, 328.
12. Peters P. W., Stuart A., Affronti M., Kim S. C., Coleman E. R.: "Neutrophil migration is defective during recombinant human, granulocyte-inacrophage colony-stimulating factor infusion after autologous bone marrow transplantation in humans". Blood, 1988, 72 (4), 1310.
13. Demitri G. D., Spertini O., Prat E. S. et al : "GM-CSF and G-CSF have different effects on expression of the neutrophil adhesion receptors LAMI & CD11b". Blood, 1990, 76, 178.
14. Shamseddine A. I.: "Granulocyte macrophage colony stimulating factor (GM-CSF) for treatment of chemotherapy extravasation". Proc. Am. Soc. Clin. Oncol., 1994, 13, 458 (abstr 1588).
15. Lindemann A., Riedel D., Oster W., Ziegkr-Heitbrock L. H. W., Mertelmann R , Herrmann F.: "Granulocyte-macrophage colony-stimulating factor induces cytokine secretion by human polymorphonuclear leukocytes". J. Clin. Invest., 1989, 83, 1308.
16. Wing J. E., Magee M., WhiteSide L. T., Kalan S. S., Shadduck K. R.: "Recombinant human granulocyte-macrophage colony-stimulating factor enhances monocyte cytotoxicity and secretion of tumor necrosis factor and interferon in cancer patients". Blood, 1989, 73, 643.